Implementation of research for healthcare
Implementation of genomics and translating advanced diagnostics from research to healthcare and precision medicine
SciLifeLab works strategically to increase collaborations striving for accelerated implementation of novel research technologies and findings of social benefit linked to health and the healthcare system.
The Clinical Genomics platform is the national research infrastructure for the development, validation and implementation of new high-throughput technologies for clinical and translational research projects, clinical trials, and diagnostics within healthcare. SciLifeLab also collaborate closely with the Genomic Medicine Sweden (an initiative originating from SciLifeLab) regarding technological development in this area.
The Clinical Proteomics and Immunology and Spatial And Single Cell Biology provides technologies, services, and expertise within the field of state-of-the-art mass spectrometry (MS), affinity proteomics and single cell analyzing tools for advanced protein analyses in body fluids, cells and tissues. The services allow studies of proteins in clinical and basic research projects.
Covid-19 – new processes and relations beyond the pandemic
By engaging the entire SciLifeLab research community and utilizing our national infrastructure, SciLifeLab has delved into creating world-class capabilities for analyzing and inhibiting COVID-19 at the molecular, cellular, patient, population and environmental level. Read more about the work and fins info about the SciLifeLab COVID-19 research seminar here:
Pandemic Laboratory Preparedness (PLP) capability
SciLifeLab is commissioned by the government to build capacity to be equipped to assist in future pandemics. The assignment is to optimize SciLifeLab operations to support and complement other societal functions such as authorities, municipalities and regions in pandemic laboratory preparedness.
Precision Medicine (PM) capability
SciLifeLab aims to bring cutting-edge technologies and first-class expertise directly to hospitals, building the foundation of tomorrow’s data-driven Precision Medicine.Precision Medicine
For efficient and sustainable use of health data through the integration of the DIGITAL-projects and GMS in Sweden (DIGIfor1healthSE).
This collaboration project is funded by the Swedish Innovation Agency Vinnova and aims to maximize the effective use of the expertise that exists jointly within the European health data DIGITAL-projects in collaboration with the national initiative Genomic Medicine Sweden (GMS). The project is based on the previously conducted feasibility study coordinated by SciLifeLab and funded by the Swedish Innovation Agency Vinnova where working groups of experts and the Swedish leads for Digital Europe Projects within health data European Genomic Data Infrastructure (GDI), European Federation for Cancer Images (EUCAIM) , European Digital Innovation Hub Health Data Sweden (HDS) and Testing and Experimentation Facility for Health, AI and Robotics (TEF-Health) participated. Among others, the issues in terms of legal aspects, semantic interoperability, technical infrastructure, and data security for long-term solutions for health data management were highlighted. Read more here:
DIGIfor1healthSE is conducted during year 2024-2027 in order to further contribute to coordination nationwide for increased use of health data for excellent research, sustainable precision health,and strengthened Swedish competitiveness and attractiveness. DIGIfor1healthSE also supports national development towards introducing the European Health Data Space. GMS as a national infrastructure in precision medicine also actively participates. SciLifeLab, as national infrastructure within Life Sciences and an active part in these initiatives, coordinates the project. The website will be available by April 2024 as latest.